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Abstract
Objective: African-American men have an incidence rate of prostate cancer 60% higher than
Caucasian men. Over one-quarter of men with prostate cancer experience signiﬁcant distress,
yet psychosocial research has rarely focused on African-American men. This study presents
novel data on emotional well-being, distress, anxiety, and depression in African-American men
with prostate cancer.
Methods: This archival research combined two databases (N5 385 and N5 367) comprised
of 55 African-American men with prostate cancer. Quality of life was assessed with the
Functional Assessment of Cancer Therapy, distress was measured with the Distress
Thermometer, and anxiety and depression were measured with the Hospital Anxiety and
Depression Scale. African-American and Caucasian men were matched on age, education, and
stage of disease, and compared on emotional well-being, distress, anxiety, and depression.
Results: The mean age of the 55 African-American was 63 years old. In non-matched
comparison, African-American men had elevated levels of distress, anxiety, and depression
similar to Caucasian men. African-American men reported high levels of clinically signiﬁcant
distress (>31%) and anxiety (>23%). However, after matching the African-American and
Caucasian men, African-American men reported higher mean scores on emotional well-being
(po0.05) and a lower percentage of African-American men displayed clinically signiﬁcant
depressive symptoms (po0.05) compared with Caucasian men.
Conclusions: After matching the sample, African-American men seem to display a sense of
resilience, demonstrating greater emotional well-being and a lower incidence of clinically
signiﬁcant depressive symptoms, compared with Caucasian men. This is consistent with cross-
cultural research outside of prostate cancer. Continued research is needed to further elucidate
the concept of resiliency in African-American men with prostate cancer.
Copyright r 2010 John Wiley & Sons, Ltd.
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Introduction
Prostate cancer is the most common site of cancer in
men in the United States, with over 180, 000 men
projected to be diagnosed in 2009 [1], and ranks as
the second leading cause of death in men in the
United States [1]. Not surprisingly, a signiﬁcant
number of men with prostate cancer experience
anxiety and distress at some point when dealing with
this illness. In a study of 121 mostly advanced stage
prostate cancer patients, 32.6% of men scored at or
above the anxiety cut-oﬀ score of the Hospital
Anxiety and Depression Scale (HADS) [2], and
15.2% scored at or above the cut-oﬀ score for
depression on the HADS [3]. Zabora et al. (2001)
found, similarly, in a study of psychological distress
by cancer site, that 30.5% of 167 prostate cancer
patients had signiﬁcant psychological distress based
on a self-report rating scale, the Brief Symptom
Inventory (BSI) [4,5], consistent with the estimates
that 25–30% of all cancer patients meet diagnosis
criteria for a major depressive disorder or an anxiety
disorder. [6–9]. Some causes of the anxiety found
amongst these men with prostate cancer include
worries about side eﬀects of their medical treatment,
metastasis of their disease, disability, death, and
‘PSA Anxiety’ [10], the anxiety associated with
Prostate Speciﬁc Antigen (PSA) testing.
African-American men are particularly vulner-
able towards prostate cancer with an incidence rate
that is 60% higher than Caucasian men [11].
African-American men have a greater likelihood
of being diagnosed with advanced cancer [12] and
2.3 times greater likelihood of dying from the
disease as compared with Caucasian men [11].
African-American men are also more likely to be
diagnosed at a younger age [13]. These factors are
compounded by the reality that African-American
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men are less likely to have appropriate knowledge
of the risks of prostate cancer [14–18] or to have a
digital rectal exam [19, 20].
These realities for African-American men may
impact how they cope with their disease. To
illustrate, Abrams et al. (1990) suggest that age
may be the most important factor that determines a
person’s psychological response to a diagnosis of
cancer, and younger men with school age children
may react very diﬀerently than a relatively older
man with adult age children [21]. Similarly, the
stage of diagnosis can also have a distinct impact
on how a person reacts to a cancer diagnosis or
treatment [22], and if African-American men are
diagnosed with later stage disease they may be
experiencing more distress as a result. Despite these
statistics however, psychosocial research under-
taken in men with prostate cancer generally lacks
appropriate sampling of African-American men,
and research that focuses speciﬁcally on distress,
anxiety, and depression in African-American men
with prostate cancer is quite limited [21].
The primary psychosocial research conducted in
African-American men with prostate cancer has
focused on general quality of life measures. This
initial research suggests that African-American
men score lower on quality of life measures as
compared with Caucasians. In a study comprised
of 958 Caucasian and 161 African-American men
newly diagnosed with prostate cancer, which
controlled for age, education, and income level,
Lubeck et al. (2001) found that African-American
men had lower quality of life ratings on almost all
health speciﬁc and general dimensions on the SF-
36 at baseline and follow-up assessments [23]. In
addition, while quality of life of both African-
American and Caucasian men improved a year
after follow-up, African-American men’s worry
about their disease improved at a slower rate than
Caucasians. Also, Caucasian men reported better
self-esteem, emotional, and mental health than
African-American patients at both the 3 and
12-month follow-up. Jenkins et al. (2004) examined
the quality of life and impact of cancer on sexuality
in a sample of men from the Cleveland Clinic
database [24]. From a sample of 1, 112 Caucasian
men and 118 African-American men who averaged
4.5 years past localized treatment [24], African-
American men reported slightly lower scores on
mental health (two points), were less likely to
report an impact on erections or sexual satisfac-
tion, and were more likely to report a loss of libido.
Together these studies imply that quality of life is
lower in African-American men with prostate
cancer; however, these studies do not address
incidences of distress, depression, or anxiety speci-
ﬁcally. This is not necessarily surprising as there is
often general lack of clarity in the literature about
what is meant by quality of life constructs such as
‘emotional well-being’ or general psychological
constructs such as ‘distress’. Distress is generally
considered to be a combination of feelings such as
worry, anxiety, fear, and depression. The most
common assessment of distress in cancer patients is
an eﬃcient one-question screen (i.e. The Distress
Thermometer) that is used to determine if further
evaluation should be considered [25]. Emotional-
well being is commonly assessed within quality of
life measures, and like distress, also combines the
constructs of anxiety and depression [26]. Emotional
well-being scales are usually longer (around 4 or 5
questions) and are considered more psychometri-
cally sound as compared with the one-question
distress measures. Although these concepts and
scales are useful for identifying general distress,
they lack the ability to make the distinction between
anxiety and depression. We believe this distinction is
important in order to assist clinicians to better
understand and treat psychological diﬃculties in
this population.
The current study, therefore, aims to elucidate the
incidence of these markers of psychological distress,
anxiety, and depression as well as emotional well-
being within African-American men with prostate
cancer, and in so doing to contribute to the dearth
of scientiﬁc literature in this area. To do this, we
used archival data including measures of depression,
anxiety, and emotional well-being from 752 men
with prostate cancer generally divided equally
between early and late-stage disease. We hypothe-
sized based on the studies listed above where
African-American men with prostate cancer re-
ported poorer quality of life, that African-American
men would report higher levels of distress, anxiety,
and depression, and lower levels of emotional well-
being compared with Caucasian men.
Methods
Participants
The study utilized two separate samples, both
investigating quality of life, distress, anxiety, and
depression in men with early and late-stage prostate
cancer. The ﬁrst database consisted of data from
385 men from doctors’ oﬃces throughout the US.
The average age for the participants was 71 year old
(79 years). The majority were Caucasian (86%),
and 10% were African-American. Roughly half had
early stage disease (55%) and the remainder has
late-stage disease. The average time since diagnosis
was 4.4 years (74). A large percentage (42%) had a
college or advanced degree. The majority were
married or in a committed relationship (83%). The
second database was based on 367 men from the
prostate clinics at our institution. The average age
from this sample was 66 years old (79 years). The
majority of participants were Caucasian (89%),
while 6% were African-American. Almost half
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(45%) had early stage disease, and the remainder
had late-stage disease. The average time since
diagnosis was 5.2 year (74.5). A majority (73%)
had earned a college degree or higher. The majority
(84%) were married or in a committed relationship.
When combining both databases a total of 752
subjects comprised the total sample. When account-
ing for 29 subjects who had missing data on all the
variables utilized in this analysis, a total number of
723 were available for analysis. We were speciﬁcally
interested in two subgroups for analysis in this
paper; the 55 (8%) African-American men available
in the data pool, and the 631 (87%) Caucasian
men as a comparison group. When combining the
Caucasian and African-American men, there were
686 subjects used for this analysis. The remaining
35 (5%) subjects were identiﬁed as Hispanic
(non-African-American), Asian, or ‘other’ ethnic
background. We did not include Hispanics (non-
African-American), Asian, or ‘other’ ethnic identi-
ties in the comparison group with the Caucasian
men because these groups are unique cultures that
may have their own ethnically speciﬁc ways of
dealing and coping with stressful situations.
To control for speciﬁc variables, we matched an
equal sample of Caucasian men to the African-
American men. We selected to match the samples
on age, education (college graduate vs not college
graduate), and stage of disease (early vs late). One
African-American subject did not have this demo-
graphic data recorded, and as a result we matched
54 Caucasian men to 54 African-American men. As
experimental control is fundamentally distinct
from statistical control, we elected to match
subjects on these variables as opposed to control-
ling for them statistically [27]. We recognize that it
is always important to understand that the larger
sample may vary systematically on the variables
that we used to match, however, this helps to
understand the diﬀerences between the matched
Caucasian sample and the non-matched Caucasian
sample. Age and stage of disease were chosen
because data suggests that African-American men
are diagnosed at a younger age with later stage
disease, and these variables may have an impact on
the amount of distress men experience as a result of
prostate cancer (please see introduction). Socio-
economic status (SES) is also an important variable
where there may be diﬀerences between African-
American men and Caucasian men, and these
diﬀerences may impact distress [28]. However, as
we did not have socio-economic data, education
was selected as a proxy for SES. Although not
ideal, education is considered a relatively good
proxy for SES [27].
Procedure
The eligibility requirements for both studies
included English ﬂuency, diagnosis of prostate
cancer, age greater than 18 years, and monitoring
of prostate serum antigen (PSA) levels. Patients
were recruited consecutively as they came to their
appointments with their prostate cancer physician.
One goal of recruitment was to recruit an equal
number of men with early and late-stage disease.
Patients who met the eligibility criteria were asked
to complete a series of seven self-report question-
naires as they waited for their doctor’s visit. The
questionnaires were completed before they received
the results of their PSA test for that speciﬁc
visit. Data from the following questionnaires were
analyzed in this study: The Distress Thermometer
[3], the HADS [29], the Functional Assessment of
Cancer Therapy (FACT-G) [30,31], and a demo-
graphics questionnaire that included treatment
course and co-morbidities.
Measures
The Distress Thermometer is a 1-item visual analog
scale (picture of thermometer), which asks patients to
rate their distress on a 0–10 scale. This scale has
demonstrated good convergent and discriminant
validity in studies with cancer patients as compared
with longer measures used to screen for distress
[32,33] Research suggests that a cut-oﬀ of 4 or greater
warrants referral for mental health assessments [32].
Depression and anxiety were measured by the
HADS [2]. This is a 14-item self-report question-
naire, which has been well tested in cancer
populations. Responses are scored on a 4-point
scale, and the measure is considered particularly
useful for patients with chronic diseases because of
the absence of somatic items that often confound
the determination of psychiatric problems among
the medically ill. As its name implies, the HADS
has a depression and anxiety subscale, each
consisting of 7 items. The HADS has demonstrated
strong test–retest reliability in both elderly patients
and patients with AIDS [34,35]. A number of cut-
oﬀ scores for the HADS have been deﬁned which
indicate signiﬁcant depression or the need for
referral in cancer patients [36]. As none of these
studies have speciﬁcally validated the cut-oﬀ scores
in men with prostate cancer or African-American
men with prostate cancer, we elected to use a more
stringent cut-oﬀ for the total HADS score of X16,
andX8 for the two subscale scores, consistent with
research that found a cut-oﬀ of 8 to be optimal for
lung cancer patients [2,37–39]. The analysis used
HADS scores as both a continuous variable and
a dichotomous variable, as we felt the continuous
variable would tap levels of depressive symptoms
and we were interested in a cut-oﬀ score that would
be more appropriate at deﬁning signiﬁcant depres-
sion. As such, we opted to use the higher cut-oﬀ
scores for this study.
Emotional well-being was measured with the
emotional well-being subscale of the FACT-G
1054 C. J. Nelson et al.
Copyright r 2010 John Wiley & Sons, Ltd. Psycho-Oncology 19: 1052–1060 (2010)
DOI: 10.1002/pon
[30,31]. The FACT-G is a quality of life ques-
tionnaire which includes a 27-item ‘core’ quality of
life measure grouped into four subscales: physical
well-being, social/family well-being, emotional
well-being, and functional well-being. The FACT-
G items are rated on a 5-item Likert scale, from 0,
‘not at all’ to 4, ‘very much’. The internal
consistency of the subscales of the FACT-G range
from acceptable to excellent, from 0.65 to 0.82. The
total FACT-G demonstrates excellent internal
consistency with an alpha coeﬃcient of 0.89. The
test–retest reliability of the FACT-G is also
excellent within a 7-day period, with correlations
ranging from 0.82 to 0.92 [30].
Statistical analysis
Descriptive statistics were reported for both the
African-American sample and the Caucasian sam-
ple. Results for both matched and non-matched
Caucasian samples were included for analysis in
order to show that without proper variable control,
results can potentially be misleading. Independent
measures t-tests were used when examining the
diﬀerences on continuous variables between the
groups in the non-matched sample. Matched
samples t-tests were used when examining the
diﬀerence in continuous variables between the
groups in the matched sample. The percentage of
each group reporting signiﬁcant distress, depres-
sion and anxiety were reported (please see above
for the speciﬁc cut-oﬀ scores used). The diﬀerence
in percentages between groups was tested using
Chi-Square. As this is archival data, we calculated
the eﬀect sizes for mean comparisons needed to
have an 80% chance of ﬁnding signiﬁcance with a
two-tailed test alpha level 0.05. For the non-
matched sample, diﬀerences would generally need
to reach a Cohen’s d of 0.40, and for the matched
sample diﬀerences would need to reach a Cohen’s d
of 0.55.
Results
Participant characteristics
From the combined databases consisting of 686
subjects, there were 631 Caucasian men with a
mean age of 69 (710) years. About half (51%) had
late-stage disease. The average time since diagnosis
was 4.9 years (74.4). Eighty-four percent were
married or in a relationship and 60% had a college
education or higher. The mean age of the 55
African-American men was 63 (710) years old and
53% had late-stage disease. The average time since
diagnosis was 4.8 years (74.3). Seventy-nine
percent were married or in a relationship and
41% had a college degree or higher.
When comparing African-American men and
Caucasian men on demographic variables, there
was no signiﬁcant diﬀerence in disease stage, time
since diagnosis, or marital status. However,
African-American men were younger (63 vs 69,
po0.01), and a lower percentage had completed a
college education or higher (41 vs 60%, po0.01) as
compared with the Caucasian men.
Levels of distress, anxiety, depression, and
emotional well-being in non-matched subjects
When comparing the African-American men to the
Caucasian men, African-American men generally
reported levels of distress, anxiety, depression, and
emotional well-being similar to Caucasian men
with prostate cancer. On the Distress Thermo-
meter, there were no signiﬁcant mean diﬀerences
between African-American men and Caucasians
(See Table 1). When assessing the number of men
meeting the cut-oﬀ score ofX4, although a greater
percentage of African-American met this cut-oﬀ
compared with Caucasian men (32 vs 23%,
p5 0.12, RR5 1.39, see Table 2), this diﬀerence
did not meet statistical signiﬁcance levels.
When analyzing the HADS scores, African-
American men tended to report similar results
compared with Caucasian men, with the exception
of one result with those men meeting the cut-oﬀ on
the HADS anxiety subscale. There were no mean
diﬀerences between African-American men and
Caucasian men in total HADS, HADS depression
scores, or HADS anxiety scores (see Table 1).
When analyzing the number of men scoring above
the HADS cut-oﬀ scores, there was no signiﬁcant
diﬀerence in the number of African-American and
Caucasian scoring X16 of the HADS total scores,
or scoring X8 on the HADS depression subscale.
However, on the HADS anxiety subscale, African-
Americans reported a trend towards a signiﬁcantly
higher percent at theX8 cut-oﬀ, 24% as compared
with 15% of Caucasian men (p5 0.09, RR5 1.6,
see Table 2).
When comparing the mean levels on the Emo-
tional Well-Being subscale of the FACT, there was
no signiﬁcant diﬀerence between African-American
men and Caucasian men (See Table 1).
Table 1. Mean differences comparing the African-American
sample to the non-matched Caucasian sample
Variables African-
Americans
Caucasians non-
matched sample
p d
Mean SD Mean SD
Distress Thermometer 2.19 2.26 2.13 2.25 0.86 0.03
HADS Total 7.05 5.96 6.82 5.61 0.77 0.04
HADS Anxiety 4.26 3.77 3.90 3.37 0.45 0.11
HADS Depression 2.79 2.75 2.92 2.97 0.75 0.04
Emotional well-being 20.16 3.19 19.65 3.87 0.33 0.14
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Levels of distress, anxiety, depression and
emotional well-being in a matched sample
After matching the African-American and Cauca-
sian men on age, education, and stage of disease
(see above), African-American men continued to
display similar levels of distress as compared with
Caucasian men on the Distress Thermometer.
There was no signiﬁcant mean diﬀerence between
African-American men and Caucasians nor were
there signiﬁcant diﬀerences between African-Amer-
ican men vs Caucasian men when assessing the
percent of men meeting the cut-oﬀ score of X4.
When analyzing the mean HADS total and
subscale scores, diﬀerences did not meet statisti-
cally signiﬁcance levels; however, African-Amer-
ican men consistently demonstrated lower scores
with small eﬀects sizes (i.e. Cohen’s d approxi-
mately 0.2, see Table 3). The small eﬀect sizes
indicate that a larger sample would be needed to
demonstrate statistical signiﬁcance, and this archi-
val data set was not powered correctly to detect
these diﬀerences.
When assessing the percentage of men scoring at
the cut-oﬀ ofX16 for HADS total scores, although
the actual percentage diﬀerence is large with lower
percentage of African-American men scores below
this cut-oﬀ compared with Caucasian men, there
was no signiﬁcant diﬀerence (9 vs. 19%, p5 0.17,
RR5 2.11). There was also no signiﬁcant diﬀer-
ence between African-American men and Cauca-
sian men on the percent of men scoring X8 on the
HADS anxiety subscale (24 vs. 26%, p5 0.82,
RR5 1.08); however, a signiﬁcantly lower percent-
age of African-American men met the cut-oﬀ ofX8
on the HADS depression subscale compared with
Caucasian men (4 vs. 15%, p5 0.04, RR5 3.75).
When comparing the mean scores of the
Emotional Well-Being scale on the FACT, African-
American men reported signiﬁcantly higher emo-
tional well-being compared with Caucasian men
(20.2873.04 vs 18.1474.56, po0.01, d5 0.44, see
Table 4).
Discussion
This study aimed to answer the question of whether
there are diﬀerences in distress, anxiety, depression,
and emotional well-being between cohorts of
African-American and Caucasian men with pros-
tate cancer. Based on results from limited research
in this area, we hypothesized that African-Amer-
ican men would consistently report higher levels of
distress. Interestingly, however, we found that
African-American and Caucasian men reported
distress at similar levels in an unmatched sample,
with the exception that African-American men
showed a trend towards higher anxiety. When
comparing the African-Americans men to a Cau-
casian sample matched on age, education, and
stage of disease, a lower percentage of African-
American men reported clinically signiﬁcant
depressive symptoms (i.e.X8 on the HADS depres-
sion subscale) and greater mean scores on emo-
tional well-being. There were no signiﬁcant
diﬀerences in mean scores on HADS total scores,
or the depression and anxiety subscales on the
matched-samples; however, African-American men
consistently reported lower mean scores with a
Cohen’s eﬀect size of approximately 0.2, indicating
a small eﬀect. Unfortunately, this archival study
had power to only detect medium eﬀects, and did
not have suﬃcient power to detect these small
eﬀects as statistically signiﬁcant. One value of
archival data is to help guide future research, and
indeed, the National Cancer Institute values pre-
liminary ﬁndings from secondary analysis to justify
potential research. Taking this into account, we do
Table 3. Mean differences comparing the African-American
sample to the non-matched and matched Caucasian samples
Variables
African-
Americans
Caucasian
matched
sample
p d
Mean SD Mean SD
Distress Thermometer 2.15 2.22 2.60 2.34 0.33 0.14
HADS Total 7.12 5.94 8.89 6.25 0.12 0.21
HADS Anxiety 4.24 3.78 5.28 3.88 0.16 0.19
HADS Depression 2.84 2.74 3.61 3.25 0.16 0.18
Emotional well-being 20.28 3.04 18.14 4.56 o0.01 0.44
The means for African-American subjects changes slightly from Tables 1 and 3
because 1 African-American subject did not report demographic data and could
not be matched.
Table 2. Comparisons of percent of patients who met cut-off
scores
Variables Cut-off African-
American
Caucasian non-
matched sample
p
% %
Distress Thermometer X4 33 23 0.12
HADS total X16 9 8 0.82
HADS Anxiety X8 24 15 0.09
HADS Depression X8 4 8 0.22
Table 4. Comparisons of percent of patients who met cut-off
scores
Variables Cut-off African-
American
Caucasian
matched sample
p
% %
Distress Thermometer X4 33 25 0.39
HADS Total X16 9 19 0.17
HADS Anxiety X8 24 26 0.82
HADS Depression X8 4 15 0.04
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not view these as ‘null’ ﬁndings, but instead view
the consistency of these diﬀerences (and consis-
tency with the literature discussed below) as
markers for future research, and have provided
the eﬀects sizes to help guide appropriate sample
size calculations for subsequent studies.
As there is a general dearth of literature of
distress in African-American men with prostate
cancer, it is diﬃcult to place the results of this study
in context with other studies of distress in this
population. As a result, we will review relevant
literature on African-Americans conducted outside
of prostate cancer. Our results, while surprising,
appear to be consistent with previous research in
healthy samples which indicates that before con-
trolling for important confounding variables when
comparing African-Americans to other ethnicities,
African-Americans appear to report greater dis-
tress. However, after controlling for important
variables, as we did matching the samples on age,
education, and stage of disease, African-Americans
report reduced distress [28, 40–42]. For example, in
Sachs-Ericsson’s study, which compared results of
Caucasian and African-American elders’ responses
on the CES-D, African-Americans ﬁrst appeared
to endorse more depressive symptoms than Cau-
casians, but this eﬀect was mediated when socio-
economic factors were controlled and whites
actually endorsed more depressive symptoms. The
authors cite studies that show that Caucasians have
lower self-esteem than AA, a racial diﬀerence that
increases with age [43,44]. They also cite studies of
caregivers that found that Africans-Americans
experience less distress and depressive symptoms
[45,46] and that African-Americans have better
interpersonal functioning, which protects them
against depressive symptoms [47].
Studies that have found diﬀerences between
African-Americans’ and Caucasians’ emotion reg-
ulation and aﬀective style may also partly explain
why African-Americans report less depression. The
medical anthropological literature shows that
certain cognitive and emotional descriptors of
depression are absent in some groups [48]. Con-
sedine et al. found that African-American and
Caribbean women scored lower than other ethnic
groups on a self-report measure of anger in a
covariate analysis of a multi-ethnic group of
women (N5 1364) [49,50]. Several other studies
have also shown that African-Americans have
lower emotional expression and lower levels of
negative aﬀect [51] that may explain why African-
Americans would be less likely to endorse depres-
sive symptoms. In addition, Steward et al. [52]
found that African-Americans have a greater
reliance on humor, which has been shown to be
related positively to a number of factors associated
with psychological health, such as optimism and
self-esteem, and negatively with signs of psycholo-
gical distress [53].
African-Americans have also been shown to have
more extended families and greater social support
[54], which together may aid in preventing depres-
sive symptoms. Speciﬁcally, African-Americans may
have stronger ties to a religious community and
participate more actively in religious activities [54]
and several studies provide further evidence of the
prominence of organized religion and spirituality
within the African-American community. African-
Americans report relationships with God that are
very close and intimate, and are more likely to use
spirituality as a coping mechanism for a diﬃcult
diagnosis [55]. Indeed, Musick et al. (1998) exam-
ined the eﬀect of religious activity on depressive
symptomology among Black and White commu-
nity-dwelling elders with cancer and found that the
eﬀects of religious activity were stronger for Blacks
than Whites, and that among Blacks, religious
activity was related to lower levels of depressive
symptomology [56].
Another way to frame this discussion is to focus
on the concept of ‘resilience’. Resilience is deﬁned
by some authors as the reporting of lower
psychological symptoms [57], while other authors
have attempted to deﬁne resilience as a distinct
concept and have developed speciﬁc assessments to
measure this as a distinct outcome variable. The
research exploring resilience in African-Americans
tends to be limited and focuses on the reduction of
psychological symptoms. As such, this literature
reported similar ﬁnding as discussed above, and
has found that cultural, socio-familial, and psy-
chological resources served to inhibit psychological
distress in African-Americans exposed to stressful
life events [57]. As one study suggests, this resilience
may actually be present in African-Americans not in
spite of racism, but because of it. In a 10-year
qualitative investigation of older African-Americans’
experiences with chronic illness, Becker and Newsom
(2005) found that African-American consistently
reported themes of independence, spirituality and
survival, themes of resilience that the authors
attribute to African-American’s ongoing confronta-
tion with racism [58].
While these explanations of lower levels of
depression within the African-American community
are encouraging, it is important to consider them
within the context of mediating factors that may
distort actual levels of depression within the
African-American community. Research has shown
that African-Americans are less likely to seek mental
health care than Caucasians [59]. A study by Anglin
et al. (2008) oﬀers a possible explanation to this
discrepancy; they found that African-Americans are
more likely than Caucasians to believe that mental
health problems improve on their own, without
professional intervention [60]. Even more tellingly,
Cruz et al. (2008) found that shame and denial were
cited by African-Americans as their primary barriers
to seeking care for depression [61]. Therefore, while
Distress in African-American men with prostate cancer 1057
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increased social support and religious participation
may indeed inhibit depression, perhaps the stigma
towards depression in the African-American com-
munity distorts the accuracy of self-report measures
of depression within any African-American sample.
Likewise, the studies cited earlier that have found
diﬀerences in African-Americans’ emotional and
aﬀective style acknowledge that it is unclear whether
these diﬀerences are due to resiliency towards life
challenges or to denial of them. Finally, it is
important to note that while African-Americans
scored lower on the depression subscale of the
HADS, the fact that they scored similar to
Caucasians on the anxiety subscale indicates that
African-Americans are certainly not immune to
distress; they simply may display it diﬀerently.
We believe that there are several important
strengths of this study. Given the lack of data on
distress, anxiety, depression, emotional well-being,
or resilience in African-American men with prostate
cancer, coupled with the distinct signiﬁcance to
focus on this population, we believe that is novel
data and important to help us to begin to under-
stand the experiences of African-American men
with prostate cancer as well as generate hypotheses
for future research. We also view the broad range of
prostate cancer patients (e.g. mix of late and early
stage, and varied treatment history) as a strength
providing an overview of men’s experience and
laying the foundation that will drive future
research. However, we recognize that this non-
speciﬁcity may be viewed as a weakness of the
study, and acknowledge the need for future studies
that are more narrow in scope on the stage of
disease or treatment history. We also concede that
there are several other limitations to this study.
Because the study was conducted through archival
data, we were limited to a relatively small sample of
African-American men and we do not have data on
important variables such as measures of resilience
or beneﬁt-ﬁnding. We also do not have data on SES
status, although we believe patients’ educational
background is a reliable proxy for this component
of SES. In addition, the measures used in the study,
the Distress Thermometer and HADS, have not
been speciﬁcally validated in a sample of African-
American with prostate cancer, as they are used
here, and the study was conducted from a site with a
low concentration of African-American men, who
may therefore be exceptional and not representative
of men from community health centers with a
diﬀerent demographic. Future research is needed to
clarify the type and extent of distress in African-
American men with prostate cancer; what factors
are moderators of this distress; and if African-
American are in fact more resilient when confronted
with prostate cancer, why this is so.
In light of the nuances of African-American
culture discussed above, it is possible that African-
Americans have a qualitatively distinct perspective
of the cancer experience that fosters diﬀerent
coping mechanisms than those of other groups.
Future studies including measures of beneﬁt-ﬁnd-
ing as well as qualitative questions about the cancer
experience would be one way to begin learning
about these mechanisms.
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